This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Centre Hospitalier Régional Et Universitaire De Brest, National Institute of Health and Medical Research, Universite De Bretagne Occidentale (Ubo). Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 1,853 
1 out of 4 Years Active: 2022
Title: Yves Renaudineau: Innovator in Chronic Lymphoid Leukaemia and Systemic Lupus Erythematosus Diagnosis
Introduction
Yves Renaudineau is a notable inventor based in Brest, France. He has made significant contributions to the field of medical diagnostics, particularly in relation to chronic lymphoid leukaemia (CLL) and systemic lupus erythematosus (SLE). His innovative work has led to the development of processes that enhance the diagnosis and monitoring of these conditions.
Latest Patents
Renaudineau holds a patent for "Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (CLL) and/or of systemic lupus erythematosus (SLE) using membrane STIM 1." This patent outlines methods for the in vitro detection of the STIM1 protein's expression at the cell plasma membrane in biological samples from humans and mice. The processes described in the patent aim to improve the diagnosis and monitoring of CLL and SLE, providing valuable tools for healthcare professionals.
Career Highlights
Throughout his career, Yves Renaudineau has been associated with prestigious institutions such as the Université de Bretagne Occidentale and the Institut National de la Santé et de la Recherche Médicale. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Renaudineau has collaborated with notable colleagues, including Olivier Mignen and Marjolaine Debant. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field of medical diagnostics.
Conclusion
Yves Renaudineau's contributions to the diagnosis and monitoring of chronic lymphoid leukaemia and systemic lupus erythematosus highlight his role as an innovator in the medical field. His patent and collaborations reflect his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile